The Bill & Melinda Gates Foundation has invested tens of millions in German biotech firm CureVac.
The cash injection will help the company continue working on developing effective vaccines for diseases including Ebola, HIV and tuberculosis.
Diseases such as Ebola and Lassa fever are highly contagious and life-threatening. Three years ago more than 11,000 people died of Ebola in West Africa. There is a high risk of new epidemics in the region.
The Democratic Republic of Congo has given the green light to an experimental vaccine to combat an ongoing Ebola outbreak. While the vaccine is not licensed, it has shown promising signs in a clinical trial.
After helplessly watching 11,000 Ebola patients die in 2014, the World Health Organization now introduces a vaccine against the virus. It was developed by the Canadian government and is licensed to Merck.
© 2018 Deutsche Welle |
Legal notice |